Price T Rowe Associates Inc Gossamer Bio, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 5,494,794 shares of GOSS stock, worth $4.73 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,494,794
Previous 2,891,005
90.07%
Holding current value
$4.73 Million
Previous $3.41 Million
44.96%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GOSS
# of Institutions
103Shares Held
176MCall Options Held
453KPut Options Held
543K-
Nea Management Company, LLC Timonium, MD18.1MShares$15.6 Million1.54% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$11.4 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$10.1 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$7.9 Million1.91% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$6.93 Million4.25% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $80.8M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...